Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Clinical characteristics, risk factors, and outcome of Enterococcal bacteraemia: Assessment of the DENOVA score in a diverse patient cohort.

Infection·2026
Same author

Diagnostic discordance and differential diagnoses of community-acquired pneumonia in the emergency department.

BMC emergency medicine·2026
Same author

Association of German Bronchiectasis Registry participation with disease course.

ERJ open research·2026
Same author

Adolescent wellbeing after COVID-related school-closings.

Frontiers in psychology·2026
Same author

Management of Adult Bronchiectasis: Consensus-Based Guidelines of the German Respiratory Society.

Respiration; international review of thoracic diseases·2026
Same journal

The Prevalence of Hospitalized Cases of Necrotizing Fasciitis: Anatomical Distribution, Amputations, and In-Hospital Mortality, 2019-2024.

Deutsches Arzteblatt international·2026
Same journal

Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.

Deutsches Arzteblatt international·2026
Same journal

Fewer Premature Births After Assisted Reproduction.

Deutsches Arzteblatt international·2026
Same journal

Femoral Artery Pseudoaneurysm Due to Stent Fracture in PAOD.

Deutsches Arzteblatt international·2026
Same journal

Pain-Adapted Full Weight-bearing After Ankle Fracture Surgery: A Multicenter, Pragmatic, Single-armed Prospective Study.

Deutsches Arzteblatt international·2026
Same journal

Popliteal Artery Entrapment Syndrome.

Deutsches Arzteblatt international·2026
See all related articles

Related Experiment Videos

Bronchiectasis--diagnosis and treatment.

Jessica Rademacher1, Tobias Welte

  • 1Klinik für Pneumologie, Medizinische Hochschule Hannover.

Deutsches Arzteblatt International
|January 3, 2012
PubMed
Summary
This summary is machine-generated.

Bronchiectasis in chronic obstructive pulmonary disease (COPD) is increasingly common. Current treatments for non-cystic fibrosis bronchiectasis lack strong evidence, with new therapies under investigation.

Related Experiment Videos

Area of Science:

  • Pulmonology
  • Respiratory Medicine

Background:

  • Bronchiectasis is a common complication in advanced chronic obstructive pulmonary disease (COPD), affecting 30-50% of patients.
  • The global prevalence of COPD is rising, leading to a parallel increase in bronchiectasis cases.

Purpose of the Study:

  • To review current treatment principles and emerging therapies for bronchiectasis in patients without cystic fibrosis (non-CF bronchiectasis).

Main Methods:

  • A selective PubMed search was conducted for pertinent articles published before May 2011.
  • Review of existing literature on treatment strategies for non-CF bronchiectasis.

Main Results:

  • Treatment principles for non-CF bronchiectasis borrow from cystic fibrosis (CF) and COPD management, including secretolytic, anti-infectious, and anti-obstructive approaches.
  • Limited randomized trials exist, hindering evidence-based recommendations. Hypertonic saline shows no proven benefit in non-CF bronchiectasis.
  • Inhaled mannitol shows promise in Phase II trials, with Phase III trials ongoing. Inhaled antibiotics and macrolides may offer benefits, particularly for Gram-negative pathogen colonization, but require careful monitoring for efficacy.

Conclusions:

  • A national registry for bronchiectasis patients is needed to improve understanding of prognostic factors and treatment outcomes.
  • Further research and clinical trials are essential to establish evidence-based treatment guidelines for non-CF bronchiectasis.